Practitioner perspectives on meditation-based preparation for psychedelic experiences

The potential of meditation as a preparatory tool for psychedelic experiences lacks empirical investigation. We surveyed experienced practitioners (N=123) with substantial histories in both meditation and psychedelic use to examine meditation’s role in psychedelic preparation. Respondents expected meditation training to primarily enhance acceptance and present-moment focus during psychedelic experiences, while also increasing oceanic boundlessness and reducing anxious ego-dissolution. For practitioners with limited meditation experience (1-3 years) and fewer psychedelic sessions (1-20), those adhering to specific meditation traditions reported significantly higher PBMPP scores (Perceived Benefits of Meditation for Psychedelic Preparation) compared to non-adherents. However, among highly experienced meditators (10+ years) with limited psychedelic experience (1-20 sessions), this pattern reversed, with non-adherents reporting significantly higher PBMPP scores than adherents to specific tradition. When evaluating specific meditation approaches, Loving-Kindness Meditation emerged as the most beneficial preparatory practice, significantly outrating other approaches such as Focused Attention. Exploratory factor analysis of meditative elements identified three distinct components: Positive Emotional States (PES), Mindful Awareness and Insight (MAI), and Concentration Techniques (CT), with PES receiving the strongest endorsement for psychedelic preparation. For practical implementation, participants recommended approximately three weeks of preparation with 30-minute daily sessions, strongly favouring online and asynchronous delivery methods. These results provide empirical groundwork for developing effective evidence-based meditation protocols for psychedelic preparation. They also highlight the importance of considering psychedelic users’ level of previous meditation experience in optimising such interventions. Future research directions should include controlled trials examining specific meditation practices’ effects on psychedelic experiences and outcomes across different populations and contexts.